risankizumab,infliximab,certolizumab,golimumab,guselkumab,adalimumab,etanercept,bimekizumab,ustekinumab,ixekizumab,secukinumab
janssen,abbvie,ucb pharmaceuticals,eli lilly,boehringer ingelheim,amgen,novartis,pfizer
['etanercept', 'ustekinumab', 'guselkumab', 'adalimumab', ' psa', 'ixekizumab', 'risan', 'secukinumab', 'bimekizumab', 'infliximab', 'golimumab', 'certolizumab']
meds for psa at #eular2023 recommendations
bdmard after csdmard (no order proposed) 
Rheumatologist @HSpecialSurgery @WeillCornell ClinicalResearch | Big Data | Outcomes | Epidemiology | Disparities | Table tennis player | Tweets are my own.